Back to search

University of Southampton

Elucidating the role of ADAM33 in airway inflammation and remodelling in asthma

Abstract

dc:description.abstract

<p style="margin: 0cm 0cm 0pt;">Asthma is a heterogeneous chronic inflammatory disease characterised by recurrent, reversible airflow obstruction, bronchial hyperresponsiveness (BHR) and airway remodelling. Impaired lung function in childhood asthma has been associated with polymorphisms in <i>ADAM33</i>. Soluble ADAM33 (sADAM33) is increased in bronchial lavage fluid (BALF) from asthmatics and is inversely correlated with FEV1. sADAM33 is induced by TGF-β present in asthmatic lungs, and promotes angiogenesis. ADAM33 expression is developmentally regulated and is influenced by maternal allergy via IL-13. This thesis will examine the hypothesis that alteration in the expression of ADAM33 will influence lung structure, affecting vessel and smooth muscle formation and these subsequent changes will impact on pulmonary function in airway inflammation. </p> <p style="margin: 0cm 0cm 0pt;"> </p> <p style="margin: 0cm 0cm 0pt;">In DOX inducible <i>Il-13</i> transgenic mice, significant neutrophilic inflammation and goblet cell metaplasia were observed. BHR was induced after methacholine challenge and IHC showed increased bronchial smooth muscle. Similarly, in human embryonic and juvenile mouse lungs, IL-13 suppressed <i>Adam33</i> mRNA but not <i>Acta2</i>. ADAM33 was identified in BALF of the overexpressing mice. ADAM33 enzymatic activity was also significantly increased. In the <i>ADAM33</i> transgenic model, induction of ADAM33 resulted in enzymatically active sADAM33 in BALF. ADAM33 significantly increased the expression of fibrotic markers suggesting regulation of pulmonary myogenesis, fibrogenesis, and angiogenesis. Consistent with this, immunofluorescence revealed airway remodelling with increased smooth muscle, collagen deposition and vessel formation in <i>ADAM33</i> mice. In contrast, inflammatory cell counts in BALF, expression of inflammatory mediators and mucus related genes were not altered by <i>ADAM33</i>. In Adam33 -/- challenged with HDM, there was less BHR and eosinophilic and neutrophilic inflammation compared to Adam33 +/+. HDM caused suppression of <i>Adam33</i> mRNA as well as ectodomain shedding of ADAM33 protein in BALF of wildtype mice that was absent in <i>Adam33</i> -/-.</p> <p style="margin: 0cm 0cm 0pt;"><br/> The study provides novel data showing expression of sADAM33 in airways to induce myogenesis, fibrogenesis and angiogenesis, consistent with a process causing airway remodelling in the absence of inflammation.</p>

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Davies, Elizabeth R.
Advisor dc:contributor.advisor
  • Haitchi, Hans
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Davies, Elizabeth R.. Elucidating the role of ADAM33 in airway inflammation and remodelling in asthma. doctoral thesis, University of Southampton, 2014.